Hypercalcemia in children: An overview

Pediatrics International

Volumn 39, Issue 4, 1997, Pages 479-484

  Nishiyama, Soroku ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Familial hypocalciuric hypercalcemia; Idiopathic hypercalcemia; Immobilization; Vitamin D intoxication; Vitamin D related hypercalcemia

Indexed keywords

CALCIUM; COMPLEMENTARY DNA; PARATHYROID HORMONE; VITAMIN D;

BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CHILD; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENE MUTATION; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCIURIA; IMMOBILIZATION; INFANT; NEWBORN; PARATHYROIDECTOMY; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; VITAMIN D INTOXICATION;

CALCIUM-BINDING PROTEINS; CHILD; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; INFANT; OSTEOGENESIS; VITAMIN D;

EID: 0030772969     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1997.tb03624.x     Document Type: Article

References (30)

1. McKusick VA. Mendelian Inheritance in Man: Catalogs of Autosomal Dominant, Autosomal Recessive, and X-linked Phenotype, 8th edn. Johns Hopkins University Press, Baltimore, 1988.
2. Goldbloom RB, Gillis DA, Prasad M. Hereditary parathyroid hyperplasia: a surgical emergency of early infancy. Pediatrics 1972; 49: 514–23.
3. Marx SJ, Attie MF, Speigel AM et al. An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N. Engl. J. Med. 1982; 308: 257–64.
4. Steinman B., Gnehm HE, Rao VH et al. Neonatal severe primary hyperparathyroidism and alkatonuria in a boy born to related parents with familial hypocalciuric hypercalcemia. Helv. Pediatr. Acta. 1984; 39: 171–86.
5. Sopwith AM, Burns C., Grant DB et al. Familial hypocalciuric hypercalcemia associated with neonatal severe primary hyperparathyroidism and possible linkage with HLA haplotype. Clin. Endocrinol. 1984; 21: 57–64.
6. Marx SJ, Fraser D., Rapoport A. Familial hypocalciuric hypercalcemia: mild expression of the gene in heterozygotes and severe expression of the gene in homozygotes. Am. J. Med. 1985; 78: 15–22.
7. Page LA, Hadaow JE. Self-limited neonatal hyperparathyroidism in familial hypocalciuric hypercalcemia. J. Pediatr. 1987; 111: 261–4.
8. Harris SS, D'Ercole AJ. Neonatal hyperparathyroidism: the natural course in the absence of surgical intervention. Pediatrics 1989; 83: 53–6.
9. 2+ sensing receptor from bovine parathyroid. Nature 1993; 366: 575–80.
10. 2+-sensing receptor gene causes familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 1297–303.
11. 2+-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am. J. Hum. Genet. 1995; 56: 880–6.
12. 2+-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am. J. Hum. Genet. 1995; 56: 1075–9.
13. 2+-sensing receptor gene. J. Clin. Endocrinol Metab. 1995; 80: 2594–8.
14. Heath H., Odelberg S., Lackson CE et al. Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J. Clin. Endocrinol. Metab. 1996; 81: 1312–17.
15. Pearce SHS, Trump D., Wooding C. et al. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J. Clin. Invest. 1995; 96: 2683–92.
16. Pollak MR, Chou Y-HW, Marx SJ et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism: Effects of mutant gene dosage on phenotype. J. Clin. Invest. 1994; 93: 1108–12.
17. Spiegel AM, Harrison HE, Marx SJ, Brown EM, Aurbach GD. Neonatal primary hyperparathyroidism with autosomal dominant inheritance. J. Pediatr. 1977; 90: 269–72.
18. Wilkinson H., James J. Self limiting neonatal primary hyperparathyroidism associated with familial hypocalciuric hypercalcemia. Arch. Dis. Child. 1993; 69: 319–21.
19. Nishiyama S., Tomoeda S., Inoue F., Ohta F., Matsuda I. Self-limited familial hyperparathyroidism associated with hypercalciuria and renal tubular acidosis in three siblings. Pediatrics 1990; 86: 421–7.
20. Heath H III. Familial benign (hypocalciuric) hypercalcemia, a troublesome mimic of mild primary hyperparathyroidism. Endocrinol. Metab. Clin. North Am. 1989, 18: 723–40.
21. Marx SJ, Attie MF, Levine AM, Spiegel AM, Downs RW, Lasker RD. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features of fifteen kindreds. Medicine 1981; 60: 397–412.
22. 3: Application to hyper-vitaminosis D. J. Clin. Invest. 1976; 58: 61–70.
23. Garabedian M., Jacqz E., Guillozo H. et al. Elevated plasma 1,25-dihydroxyvitamin D concentration in infants with hypercalcemia and an elfin facies. N. Engl. J. Med. 1985; 312: 948–52.
24. Goodyer PR, Frank A., Kaplan BS. Observations on the evolution and treatment of idiopathic infantile hypercalcemia. J. Pediatr. 1984; 105: 771–3.
25. Aaskog O., Aksens L., Markestad T. Vitamin D metabolism in infantile hypercalcemia. Am. J. Dis. Child. 1981; 35: 1021–4.
26. Barbour GI, Coburn JW, Statopolsky E. et al. Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal genesis of 1,25-dihydroxyvitamin D. N. Engl. J. Med. 1981; 305: 440–3.
27. Jacobus CH, Holick MF, Shao Q. et al. Hypervitaminosis D associated with drinking milk. N. Engl. J. Med. 1992; 326: 1173–7.
28. Holick MF, Shao Q., Liu WW et al. The vitamin D content of fortified milk and infant formula. N. Engl. J. Med. 1992; 326: 1178–81.
29. Naftchi NE, Via AT, Sell GH, Lowman EW. Mineral metabolism in spinal cord injury. Arch. Phys. Med. Rehabil. 1980; 61: 139–42.
30. Nishiyama S., Kuwahara T., Matsuda I. Decreased bone density in severely handicapped children and adults, with reference to the influence of limited morbidity and anticonvulsant medication. Eur. J. Pediatr. 1986; 144: 457–63.